Northern Trust
ENTX icon

Northern Trust’s Entera Bio ENTX Stock Holding History

Northern Trust’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Sell
146,854
-1,814
-1% -$2.55K ﹤0.01% 3995
2025
Q4 		$288K Hold
148,668
– – ﹤0.01% 3847
2025
Q3 		$285K Sell
148,668
-52,077
-26% -$99.6K ﹤0.01% 3847
2025
Q2 		$381K Buy
200,745
+1,914
+1% +$3.78K ﹤0.01% 3738
2025
Q1 		$338K Sell
198,831
-13,652
-6% -$29.7K ﹤0.01% 3741
2024
Q4 		$450K Buy
+212,483
New +$397K ﹤0.01% 3698

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Northern Trust's ENTX Position: Q1 2026 in Review

Northern Trust reduced its Entera Bio (ENTX) stake by 1.2% in Q1 2026, selling an estimated $2.55K and leaving 146,854 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3995.

Northern Trust first reported a position in ENTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $450K in Q4 2024. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • Northern Trust held 146,854 shares of Entera Bio worth $163K as of Q1 2026.
  • Northern Trust sold 1,814 Entera Bio shares in Q1 2026, an estimated $2.55K.
  • Entera Bio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3995 holding.
  • Northern Trust first reported a position in Entera Bio in Q4 2024 and has held it in 6 quarters since.
  • Northern Trust's Entera Bio position peaked at $450K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.